- Home
- GOCO vs MNOV Comparison
GOCO vs MNOV Comparison
Compare GOCO & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOCO | MNOV |
|---|---|---|
| Founded | 2001 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 72.7M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | GOCO | MNOV |
|---|---|---|
| Price | $2.47 | $1.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.00 | ★ $7.00 |
| AVG Volume (30 Days) | 71.3K | ★ 93.4K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $738,338,000.00 | $257,917.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.56 | N/A |
| 52 Week Low | $2.05 | $1.13 |
| 52 Week High | $21.00 | $2.06 |
Technical Indicators
Market Signals| Indicator | GOCO | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 47.84 | 69.39 |
| Support Level | $2.27 | $1.43 |
| Resistance Level | $2.56 | $1.72 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 73.13 | 88.64 |
Price Performance
Historical ComparisonAbout GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.